https://www.selleckchem.com/pr....oducts/onx-0914-pr-9
Most importantly, a single-dose vaccination of VV-CPV2-VP2 elicited substantial antibody responses and provided comparable protection for dogs with attenuated CPV2 vaccine. Collectively, this study demonstrated that VV-CPV2-VP2 could be used as a promising vaccine candidate preventing CPV2 from infection for dogs.Soft wearable actuators can help connect machines and humans, providing a personalized, ergonomic, and cooperative physical interface between people and their world. Until now, the torque of these interfaces has been li
Like
Comment
Share
